Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript

AVALON PHARMACEUTICALS INC (AVRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2010 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019133
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019131
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019129
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019128
06/30/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
06/30/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
06/30/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
06/30/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
06/30/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
06/30/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
06/30/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
06/30/2009 15-12B Form 15-12B -- Securities registration termination [Section 12(b)]
06/02/2009 8-K Quarterly results
05/28/2009 25-NSE Form 25-NSE --
05/13/2009 10-Q Quarterly Report for the period ended March 31, 2009
05/06/2009 8-K Form 8-K -- Current report
05/06/2009 425 Form 425 -- Prospectuses and communications, business combinations
04/28/2009 425 Form 425 -- Prospectuses and communications, business combinations
04/02/2009 8-K Form 8-K -- Current report
04/02/2009 425 Form 425 -- Prospectuses and communications, business combinations
03/31/2009 10-K Annual Report for the period ended December 31, 2008
03/17/2009 8-K Form 8-K -- Current report
03/10/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/17/2009 SC 13G/A GREAT POINT PARTNERS LLC reports a 4.6% stake in AVALON PHARMACEUTICALS, INC.
02/17/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/11/2009 SC 13D/A OBP Management III L.P. has filed a Schedule 13D for Avalon Pharmaceuticals, Inc.
01/30/2009 SC 13G/A Merlin BioMed Private Equity Advisors, L.L.C. reports a 6.1% stake in Avalon Pharmaceuticals Inc.
01/21/2009 SC 13G/A BIOTECHNOLOGY VALUE FUND L P reports a 8.2% stake in Avalon Pharmaceuticals, Inc.
01/14/2009 8-K Form 8-K -- Current report
01/14/2009 425 Form 425 -- Prospectuses and communications, business combinations
12/22/2008 8-K Form 8-K -- Current report
11/25/2008 8-K Form 8-K -- Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy